{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:13Z","timestamp":1786989013085,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.euroneuro.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T17:16:46Z","timestamp":1680887806000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model"],"prefix":"10.1016","volume":"71","author":[{"given":"Karlijn L.","family":"Kooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieneke C.M.","family":"Luijendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Drost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3499-7542","authenticated-orcid":false,"given":"Gerard","family":"Platenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"van Elburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-0661","authenticated-orcid":false,"given":"Roger A.H.","family":"Adan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000071829","article-title":"The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats","volume":"48","author":"Ahnaou","year":"2003","journal-title":"Neuropsychobiology"},{"issue":"8","key":"10.1016\/j.euroneuro.2023.03.008_bib0002","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of Olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"issue":"7","key":"10.1016\/j.euroneuro.2023.03.008_bib0003","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","article-title":"Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies","volume":"68","author":"Arcelus","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.euroneuro.2023.03.008_bib0004","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1017\/S0033291711000390","article-title":"Olanzapine versus placebo for out-patients with anorexia nervosa","volume":"41","author":"Attia","year":"2011","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.euroneuro.2023.03.008_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","article-title":"Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial","volume":"176","author":"Attia","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.euroneuro.2023.03.008_bib0006","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","article-title":"Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial","volume":"165","author":"Bissada","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-014-0376-7","article-title":"Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background","volume":"14","author":"Brambilla","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.03.008_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","article-title":"Olanzapine therapy in anorexia nervosa: psychobiological effects","volume":"22","author":"Brambilla","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.03.008_bib0009","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet"},{"issue":"8","key":"10.1016\/j.euroneuro.2023.03.008_bib0011","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0269881120920453","article-title":"Pharmacological treatment of acute-phase anorexia nervosa: evidence from randomized controlled trials","volume":"34","author":"Cassioli","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/s41983-020-00195-y","article-title":"Olanzapine in the treatment of anorexia nervosa: a systematic review","volume":"56","author":"\u00c7\u00f6p\u00fcr","year":"2020","journal-title":"Egypt. J. Neurol., Psychiatry Neurosurg."},{"issue":"04","key":"10.1016\/j.euroneuro.2023.03.008_bib0013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4236\/ojcd.2012.24017","article-title":"Olanzapine-associated hypothermia in an adolescent anorexic girl","volume":"02","author":"Docx","year":"2012","journal-title":"Open J. Clin. Diagn."},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2023.03.008_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","article-title":"Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats","volume":"255","author":"Dufes","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"31","key":"10.1016\/j.euroneuro.2023.03.008_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hup.2535","article-title":"Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis","volume":"31","author":"Dundar","year":"2016","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1098-108X(198323)3:1<27::AID-EAT2260030104>3.0.CO;2-T","article-title":"A theory of activity-based anorexia","volume":"3","author":"Epling","year":"1983","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2023.03.008_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2010.05.029","article-title":"Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats","volume":"97","author":"Evers","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"10","key":"10.1016\/j.euroneuro.2023.03.008_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jne.12479","article-title":"A focus on reward in anorexia nervosa through the lens of the activity-based anorexia rodent model","volume":"29","author":"Foldi","year":"2017","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.euroneuro.2023.03.008_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jneumeth.2017.09.018","article-title":"Establishment of a chronic activity-based anorexia rat model","volume":"293","author":"Frintrop","year":"2018","journal-title":"J. Neurosci. Methods"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2023.03.008_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.12.046","article-title":"Nanoparticle transport across in vitro olfactory cell monolayers","volume":"499","author":"Gartziandia","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.euroneuro.2023.03.008_bib0022","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biopsych.2005.04.008","article-title":"Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa?","volume":"58","author":"Hillebrand","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2023.03.008_bib0023","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/eat.22441","article-title":"Prevalence and management of oropharyngeal dysphagia in patients with severe anorexia nervosa: a large retrospective review","volume":"49","author":"Holmes","year":"2016","journal-title":"Int. J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0024","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JCP.0b013e3181db8715","article-title":"Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in taiwan","volume":"30","author":"Hsu","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/cap.2010.0139","article-title":"A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa","volume":"21","author":"Kafantaris","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2023.03.008_bib0026","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0027","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajem.2004.02.021","article-title":"Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia","volume":"22","author":"Kinon","year":"2004","journal-title":"Am. J. Emerg. Med."},{"issue":"7","key":"10.1016\/j.euroneuro.2023.03.008_bib0028","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2012.7","article-title":"Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice","volume":"37","author":"Klenotich","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2023.03.008_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(01)00630-X","article-title":"Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol","volume":"71","author":"Lee","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0030","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1152\/ajpendo.00340.2014","article-title":"Physical activity: benefit or weakness in metabolic adaptations in a mouse model of chronic food restriction?","volume":"308","author":"M\u00e9quinion","year":"2015","journal-title":"Am. J. Physiol. - Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.euroneuro.2023.03.008_bib0031","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3565(24)35345-5","article-title":"Atypical antipsychotics and dopamine D1 receptor agonism: an in vivo experimental study using core temperature measurements in the rat","volume":"292","author":"Oerther","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0032","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1037\/h0025205","article-title":"Self-starvation of rats living in activity wheels on a restricted feeding schedule","volume":"64","author":"Routtenberg","year":"1967","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.euroneuro.2023.03.008_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnhum.2020.596381","article-title":"Animal models for anorexia nervosa\u2014a systematic review","volume":"14","author":"Scharner","year":"2021","journal-title":"Front. Hum. Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.03.008_bib0034","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.4088\/JCP.19m13086","article-title":"The SNAP 101 double-blind, placebo\/active-controlled, safety, pharmacokinetic, and pharmacodynamic study of INP105 (Nasal Olanzapine) in healthy adults","volume":"81","author":"Shrewsbury","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2023.03.008_bib0035","first-page":"197","article-title":"Evaluation of the effectiveness and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescents: an open-label trial","volume":"27","author":"Spettigue","year":"2008","journal-title":"J. Can. Acad. Child Adolescent Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2023.03.008_bib0036","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","article-title":"The outcome of anorexia nervosa in the 20th century","volume":"159","author":"Steinhausen","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2023.03.008_bib0037","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FBP.0b013e3283512ca1","article-title":"Olanzapine and sibutramine have opposing effects on the motivation for palatable food","volume":"23","author":"van der Zwaal","year":"2012","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0038","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2007.11.078","article-title":"Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution","volume":"585","author":"van der Zwaal","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.03.008_bib0039","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2010.05.009","article-title":"Olanzapine affects locomotor activity and meal size in male rats","volume":"97","author":"van der Zwaal","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2023.03.008_bib0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0237096","article-title":"RandoMice, a novel, user-friendly randomization tool in animal research","volume":"15","author":"Van Eenige","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.euroneuro.2023.03.008_bib0041","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.03.008_bib0042","first-page":"1","article-title":"The Utility of Animal Models for Studying the Metabo-Psychiatric Origins of Anorexia Nervosa","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.03.008_bib0043","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pnpbp.2014.02.003","article-title":"Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats","volume":"51","author":"Zhang","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:05:45Z","timestamp":1760378745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X23000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S0924977X23000512"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.03.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}